Amoy Diagnostics Co Ltd
SZSE:300685

Watchlist Manager
Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd
SZSE:300685
Watchlist
Price: 24.8 CNY -4.62% Market Closed
Market Cap: 9.7B CNY
Have any thoughts about
Amoy Diagnostics Co Ltd?
Write Note

Amoy Diagnostics Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amoy Diagnostics Co Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Amoy Diagnostics Co Ltd
SZSE:300685
Other Operating Expenses
-ÂĄ7.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Operating Expenses
ÂĄ210.1m
CAGR 3-Years
12%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Operating Expenses
ÂĄ45.2m
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Operating Expenses
ÂĄ20m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Operating Expenses
-ÂĄ96.3m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
-8%
Imeik Technology Development Co Ltd
SZSE:300896
Other Operating Expenses
ÂĄ25.6m
CAGR 3-Years
147%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Amoy Diagnostics Co Ltd
Glance View

Market Cap
9.9B CNY
Industry
Biotechnology

Amoy Diagnostics Co., Ltd. engages in the research, development, production and sale of tumour precision medical molecular diagnostic products. The company is headquartered in Xiamen, Fujian and currently employs 1,096 full-time employees. The company went IPO on 2017-08-02. The firm provides testing reagents and testing services for tumor diagnosis. The Company’s testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The firm also provides data software to capture and analyze gene sequencing data. The firm provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.

Intrinsic Value
28 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Amoy Diagnostics Co Ltd's Other Operating Expenses?
Other Operating Expenses
-7.2m CNY

Based on the financial report for Sep 30, 2024, Amoy Diagnostics Co Ltd's Other Operating Expenses amounts to -7.2m CNY.

Back to Top